Trial
NCT05974293
A Phase IIb Study of Nabiximols for Spasticity Due to Neuromyelitis Optica Spectrum Disorders
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Michael, Levy M.D.,Ph.D.
Collaborators
Jazz Pharmaceuticals
Condition
NMO Spectrum Disorder
Intervention
Nabiximols
Why stopped
Funding was withdrawn.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-16